BUZZ-AstraZeneca Pharma India resumes surge
** Astrazeneca Pharma India Ltd surges 15.4 pct
** Top gainer among BSE largecaps
** Stock up 41.4 pct in the last five sessions
** Investors outpoint gains were due to increasing focus of the parent in listed unit vs 100 pct unlisted subsidiary
** Talk of parent looking to increase stake also help
** Recent launches and distribution deals have happened only via AstraZeneca (NYSE: AZN - news) 's listed unit
** AstraZeneca launched treatment for diabetes in India on Thursday
** Company entered into distribution deal with Sun Pharmaceutical Industries and Dr.Reddy's Labs (RM (LSE: RM.L - news) : abhishek.vishnoi.thomsonreuters.com@reuters.net)